Diabetes drug 'could cut breast cancer risk'

Diabetes drug 'could cut breast cancer risk'

Research published in PloS One has found that medication which is currently used to treat Type-2 diabetes could also prevent a number of natural and man-made chemicals from stimulating the growth of breast cancer cells.

This provides biological evidence for the previously-reported epidemiological surveys about the long-term use of metformin and the subsequent reduction in the risk of diabetes-associated cancers.

James Trosko, pediatrics professor in the College of Human Medicine's Department of Pediatrics and Human Development has found evidence for how the reduction in cancer risk operates.

He said: "While future studies are needed to understand the exact mechanism by which metformin works to reduce the growth of breast cancers, this study reveals the need to determine if the drug might be used as a preventive drug and for individuals who have no indication of any existing cancers."

Diet and fitness expert Laura Williams recently claimed that a number of factors can cause both diabetes and cancer, highlighting the reduction in the risk of developing either attained by eating a Mediterranean diet.

Find the nearest Barchester care home.